SBH
CRNX icon

Segall Bryant & Hamill’s Crinetics Pharmaceuticals CRNX Stock Holding History

Segall Bryant & Hamill’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.54M Sell
180,112
-9,365
-5% -$418K 0.09% 277
2025
Q4 		$8.82M Buy
189,477
+8,628
+5% +$384K 0.12% 247
2025
Q3 		$7.53M Buy
180,849
+4,332
+2% +$139K 0.1% 269
2025
Q2 		$5.08M Buy
176,517
+30,243
+21% +$934K 0.07% 312
2025
Q1 		$4.91M Sell
146,274
-4,124
-3% -$154K 0.08% 314
2024
Q4 		$7.69M Buy
+150,398
New +$8.41M 0.11% 267

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return